Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance

缓释免疫接种通过调节免疫优势增强HIV中和抗体和生发中心反应

阅读:2
作者:Kimberly M Cirelli,Diane G Carnathan,Bartek Nogal,Jacob T Martin,Oscar L Rodriguez,Amit A Upadhyay,Chiamaka A Enemuo,Etse H Gebru,Yury Choe,Federico Viviano,Catherine Nakao,Matthias G Pauthner,Samantha Reiss,Christopher A Cottrell,Melissa L Smith,Raiza Bastidas,William Gibson,Amber N Wolabaugh,Mariane B Melo,Benjamin Cossette,Venkatesh Kumar,Nirav B Patel,Talar Tokatlian,Sergey Menis,Daniel W Kulp,Dennis R Burton,Ben Murrell,William R Schief,Steven E Bosinger,Andrew B Ward,Corey T Watson,Guido Silvestri,Darrell J Irvine,Shane Crotty

Abstract

Conventional immunization strategies will likely be insufficient for the development of a broadly neutralizing antibody (bnAb) vaccine for HIV or other difficult pathogens because of the immunological hurdles posed, including B cell immunodominance and germinal center (GC) quantity and quality. We found that two independent methods of slow delivery immunization of rhesus monkeys (RMs) resulted in more robust T follicular helper (TFH) cell responses and GC B cells with improved Env-binding, tracked by longitudinal fine needle aspirates. Improved GCs correlated with the development of >20-fold higher titers of autologous nAbs. Using a new RM genomic immunoglobulin locus reference, we identified differential IgV gene use between immunization modalities. Ab mapping demonstrated targeting of immunodominant non-neutralizing epitopes by conventional bolus-immunized animals, whereas slow delivery-immunized animals targeted a more diverse set of epitopes. Thus, alternative immunization strategies can enhance nAb development by altering GCs and modulating the immunodominance of non-neutralizing epitopes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。